For the first time in 19 years, a team of scientists has detected a new strain of HIV. The strain is a part of the Group M version of HIV-1, the same family of virus subtypes to blame for the global ...

A multinational team led by Weill Cornell Medicine investigators developed a test that will help measure the persistence of HIV in people affected by viral strains found predominantly in Africa—a ...

A multinational team led by Weill Cornell Medicine investigators developed a test that will help measure the persistence of HIV in people affected by viral strains found predominantly in Africa - a ...

Vaccinomics--the application of genomics and bioinformatics to vaccine development--is bringing a fresh approach to the Herculean problem of making vaccines against the various HIV-1 subtypes, or ...

Nearly 37.7 million people globally are living with HIV, with 1.2 million residing in the US 1,2. Of those individuals, 13 in 100 in the US and 16 in 100 globally are unaware of their diagnosis 1,2.

The development of new classes of antiretroviral drugs, such as integrase inhibitors and CCR5-antagonistic entry inhibitors, has opened the possibility of considering regimens without NRTIs (Table 1).

Ribonucleic acid (RNA) viruses like the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are highly vulnerable to evolving over time as a result of their error-prone replication process.